ciprofloxacin
Generic: ciprofolxacin
Labeler: redpharm drugDrug Facts
Product Profile
Brand Name
ciprofloxacin
Generic Name
ciprofolxacin
Labeler
redpharm drug
Dosage Form
TABLET
Routes
Active Ingredients
ciprofloxacin hydrochloride 250 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
67296-2169
Product ID
67296-2169_45abd636-5351-8774-e063-6294a90a558b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208921
Listing Expiration
2026-12-31
Marketing Start
2023-10-01
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
672962169
Hyphenated Format
67296-2169
Supplemental Identifiers
RxCUI
UPC
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ciprofloxacin (source: ndc)
Generic Name
ciprofolxacin (source: ndc)
Application Number
ANDA208921 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 250 mg/1
Packaging
- 10 TABLET in 1 BOTTLE (67296-2169-1)
- 6 TABLET in 1 BOTTLE (67296-2169-6)
- 14 TABLET in 1 BOTTLE (67296-2169-7)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "45abd636-5351-8774-e063-6294a90a558b", "openfda": {"upc": ["0343547689100", "0343547688103"], "unii": ["4BA73M5E37"], "rxcui": ["197511"], "spl_set_id": ["3b0af0f2-1d33-1ffe-e063-6394a90aca7c"], "manufacturer_name": ["Redpharm Drug"]}, "finished": true, "packaging": [{"sample": false, "description": "10 TABLET in 1 BOTTLE (67296-2169-1)", "package_ndc": "67296-2169-1", "marketing_start_date": "20231001"}, {"sample": false, "description": "6 TABLET in 1 BOTTLE (67296-2169-6)", "package_ndc": "67296-2169-6", "marketing_start_date": "20231001"}, {"sample": false, "description": "14 TABLET in 1 BOTTLE (67296-2169-7)", "package_ndc": "67296-2169-7", "marketing_start_date": "20231001"}], "brand_name": "Ciprofloxacin", "product_id": "67296-2169_45abd636-5351-8774-e063-6294a90a558b", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 1A2 Inhibitors [MoA]", "Fluoroquinolone Antibacterial [EPC]", "Fluoroquinolones [CS]"], "product_ndc": "67296-2169", "generic_name": "Ciprofolxacin", "labeler_name": "Redpharm Drug", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ciprofloxacin", "active_ingredients": [{"name": "CIPROFLOXACIN HYDROCHLORIDE", "strength": "250 mg/1"}], "application_number": "ANDA208921", "marketing_category": "ANDA", "marketing_start_date": "20231001", "listing_expiration_date": "20261231"}